DEVICE · Unmapped registry intervention
Tantalus System
Find medicine records ·
Find other trials using this name
Clinical trial
The TANTALUS® II for the Treatment of Type 2 Diabetes
NCT01303302
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DEVICE · Unmapped registry intervention
TANTALUS system
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedThe TANTALUS® II for the Treatment of Type 2 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Tantalus SystemDEVICE
TANTALUS systemDEVICE
Sponsors & collaborators
MetaCure (USA), Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01303302 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.